Entering information on age and selected tumour characteristics—tumour size and grade, number of positive axillary nodes, and hormone receptor status—allowed for the prediction of the 10-year risk of relapse-free and overall survival [27]. The gene discussed is NR4A1; the disease is neoplasm.